Browse Pharmaceutical industry topic

Product development subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV. Nov 9, 2009 740 Ossulin[TM] Oral Insulin Data to be Presented at The San Francisco Diabetes Congress on November 6, 2009. Nov 6, 2009 263 ERYtech Pharma Starts its Pivotal Clinical Trial for GRASPA[R] in Acute Lymphoblastic Leukaemia. Nov 5, 2009 407 Antigenics Provides Details On GlaxoSmithKline's Pivotal Malaria Vaccine Trial With QS-21 Adjuvant. Nov 4, 2009 611 Inspire Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis. Nov 4, 2009 1244 BioAlliance Pharma Presents Additional US Pivotal Phase III Results on Loramyc[TM] (Miconazole Lauriad[R]) at the 47Th Annual Meeting of the IDSA. Nov 4, 2009 498 Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer's Disease. Nov 3, 2009 1157 United states : Amylin and Takeda to develop and commercialize pharmaceutical products for obesity. Nov 2, 2009 446 United States : Optimer Pharmaceuticals presents additional data from Phase 3 fidaxomicin study. Nov 2, 2009 274 NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing Spiegelmer[R] NOX-A12. Nov 2, 2009 736 Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C. Oct 31, 2009 1356 Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint in the First Phase III Clinical Trial. Clinical report Oct 29, 2009 1169 Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia. Oct 28, 2009 1490 ZymoGenetics Initiates Phase 2 Clinical Trial of PEG-Interferon lambda in Hepatitis C with Bristol-Myers Squibb. Oct 27, 2009 699 PolyMedix Completes Successful Phase 1B Clinical Study of Heparin Antagonist PMX-60056. Oct 27, 2009 1524 Impax Pharmaceuticals Initiates Second Phase III Trial of IPX066 in Parkinson's Disease. Oct 26, 2009 854 Israeli Super-Vaccine for Flu Reported, Investors Happy. Oct 25, 2009 84 Medgenics Signs Development Agreement with Major International Pharma Company. Oct 23, 2009 797 Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 in Patients With the Most Common and Aggressive Form of Brain Cancer. Oct 23, 2009 1530 Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin[R]. Oct 22, 2009 907 Trials to test H1N1 vaccine efficacy in HIV-infected pregnant women underway. Oct 21, 2009 418 Human Genome Sciences and GlaxoSmithKline Announce Full Presentation at ACR of Positive Phase 3 Study Results for BENLYSTA[TM] in Systemic Lupus Erythematosus. Oct 20, 2009 2992 BioSante Pharmaceuticals Reports Positive LibiGel[R] Safety Data in Phase III Program. Oct 20, 2009 1278 Teva Comments on Positive Results of Phase III Trial in MediWound's Debrase[R]. Oct 20, 2009 794 Alnara Pharmaceuticals' Liprotamase Demonstrates Long-Term Safety & Maintenance of Nutritional Status in Patients with CF; Results of Landmark Phase 3 Safety Study Reported. Clinical report Oct 19, 2009 1615 XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease. Oct 19, 2009 791 Calistoga Pharmaceuticals Presents Interim Clinical Efficacy Results from Ongoing Clinical Trial of CAL-101 at the International Workshop on Chronic Lymphocytic Leukemia. Oct 19, 2009 549 Updated Data from Randomized Controlled Phase II Study Evaluating Oral Apremilast in Psoriatic Arthritis Demonstrates Sustained Response at Six Months. Clinical report Oct 19, 2009 1102 Biogen Idec and Biovitrum Announce Decision to Advance Long-Acting Hemophilia B Therapy into a Registrational Trial. Oct 19, 2009 803 Trials to test H1N1 vaccine efficacy in HIV-infected pregnant women underway. Oct 18, 2009 418 Clinical and Regulatory Challenges of Applying Personalized Medicine to Clinical Trials for CNS Diseases Are Addressed at ISCTM Meeting. Oct 16, 2009 361 Inovio Biomedical Announces Initiation of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation. Clinical report Oct 15, 2009 1326 Targacept Presents Data from Highly Successful Phase 2b Trial of TC-5214 as Augmentation Treatment for Major Depressive Disorder. Oct 15, 2009 1592 Switzerland : DEWB investment holding NOXXON Pharma AG announces excellent preliminary phase I trial results for Spiegelmer[R] NOX-E36. Oct 14, 2009 280 pSivida Announces Last Patient in Phase III Iluvien[R] Trial Completes 2 Year Follow-Up Visit. Oct 14, 2009 804 Alkermes Announces Positive Results From Two Clinical Trials of ALKS 33. Oct 13, 2009 783 Bioalliance Pharma Announces Phase I Trial for Fentanyl Lauriad[R] and the Submission of a Clonidine Lauriad[R] Phase II Clinical Trial Application. Oct 12, 2009 454 Depomed Reports Results From Two Phase 3 Clinical Trials Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes. Clinical report Oct 12, 2009 1238 NOXXON Pharma AG Announces Excellent Preliminary Phase I Trial Results for Spiegelmer[R] NOX-E36 - Good Safety and Pharmacodynamic Profile and Additional Good Subcutaneous Bioavailability. Oct 12, 2009 705 United States : BioAlliance Pharma announces Phase I clinical trial for Fentanyl Lauriad. Oct 12, 2009 162 Battling swine flu: a small study revealed early clues for San Diego-based DNA vaccine company Inovio Biomedical last week. Chambers, Heather Brief article Oct 12, 2009 207 Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-2125, a TLR9 Agonist, in Combination with Ribavirin for Chronic Hepatitis C Virus Infection. Oct 7, 2009 904 Synexus Set to Target Cancer Vaccine Trials. Oct 7, 2009 369 Positive Phase II Results for GSK1838262 (XP13512) Reported for Subjects with Post-Herpetic Neuralgia and a History of Inadequate Response to Gabapentin. Clinical report Oct 5, 2009 835 Depomed, Inc. Announces Positive Top-Line Results from Phase 3 Clinical Trial of DM-1796 in Postherpetic Neuralgia. Oct 5, 2009 1015 GVK Biosciences and Quantitative Solutions Collaborate on Clinical Trial Outcome Databases. Oct 5, 2009 462 Orexigen drug appears to exceed FDA benchmarks. Chambers, Heather Brief article Oct 5, 2009 237 United States : Oncolytics' Phase III Borrows Adaptive Design in SPA Trial. Oct 3, 2009 493 Provectus Initiates Phase 1 Trial of PV-10 for Liver Cancer. Oct 1, 2009 672 Phase Forward Inks Multi-Year Agreement with Major Eastern European Pharmaceutical Company Gedeon Richter. Oct 1, 2009 792 Bristol-Myers Squibb and ZymoGenetics to Present Final Phase Ib Data on PEG-Interferon Lambda at AASLD 2009. Oct 1, 2009 897 BOSTON SCIENTIFIC REPORTS TWO-YEAR SYNTAX TRIAL DATA. Oct 1, 2009 742 FDA ACCEPTS SALIX NDA FOR PRIORITY REVIEW. Oct 1, 2009 960 Dynavax Initiates Phase 3 Registration Trial in Chronic Kidney Disease Patients for HEPLISAVTM Hepatitis B Vaccine. Sep 29, 2009 743 PolyMedix Initiates Dosing in Phase 1B Clinical Study of Novel Anticoagulant Antagonist Compound. Sep 29, 2009 852 Idera Pharmaceuticals Presents Final Data from Phase 2 Clinical Trial of IMO-2055 Monotherapy in Renal Cell Carcinoma. Sep 25, 2009 1150 Idera Pharmaceuticals Presents Interim Data from Phase 1b Clinical Trial of IMO-2055 in Combination with Tarceva[R] and Avastin[R] in Non-Small Cell Lung Cancer. Sep 23, 2009 991 ARIAD Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab. Sep 21, 2009 840 Impax Pharmaceuticals Reports Positive Results of Phase II Trial of IPX066, a Novel Formulation of Carbidopa-Levodopa for Parkinson's Disease. Sep 21, 2009 652 Drug developer tests pancreatic cancer treatment: Abraxis cites progress in treating disease that killed Patrick Swayze. Crowe, Deborah Sep 21, 2009 371 Positive Phase IIb Results for GSK1838262 (XP13512) Reported for Neuropathic Pain Associated with Post-Herpetic Neuralgia. Clinical report Sep 17, 2009 722 BioAlliance Pharma Makes Four Presentations at the 49th ICAAC Meeting Including Three Phase III Study Results with miconazole Lauriad[R] and One with Its Integrase Inhibitor. Clinical report Sep 15, 2009 663 India: Cipla in pact with Swiss major to develop anti-allergy drug. Sep 15, 2009 341 GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Planned Safety Review. Sep 14, 2009 767 Salix Pharmaceuticals Announces Statistically Significant Results for Both the Primary and Key Secondary Analyses Of Rifaximin in the Treatment of Non-Constipation Irritable Bowel Syndrome in Two Phase 3 Trials (Target 1 and Target 2). Financial report Sep 14, 2009 1402 ARIAD Announces Result of First Interim Analysis of Phase 3 Succeed Trial of Oral Ridaforolimus, Its Investigational mTOR Inhibitor, in Metastatic Sarcomas. Clinical report Sep 14, 2009 1209 Millennium Initiates Phase II Trial of Prostate Cancer Compound. Sep 11, 2009 378 United States : Pluristem begins enrollment following FDA approval for clinical trials of its PLX-PAD stem cell product. Sep 11, 2009 231 United States: MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society. Sep 11, 2009 237 Zelrix, a Novel Transdermal Patch for Migraine, Found to Provide Rapid, Consistent, and Sustained Relief for Migraine Sufferers in Phase III Trial. Sep 10, 2009 1027 Acceleron Pharma's ACE-031 Increases Lean Body Mass in Phase 1 Single Dose Clinical Trial. Sep 10, 2009 801 Halozyme Therapeutics Announces Initiation of Phase 1 Clinical Trial with Roche Biologic. Sep 10, 2009 589 Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease. Sep 10, 2009 812 Cempra Pharmaceuticals Initiates Phase 2/3 Clinical Study for an Oral Antibiotic to Treat Acute Bacterial Skin Structure Infections. Clinical report Sep 9, 2009 506 XenoPort Reports Preliminary Results From a Safety and Tolerability Trial of Arbaclofen Placarbil in Patients With Acute Back Spasms. Financial report Sep 8, 2009 1034 Seattle Genetics Achieves Milestone Under Antibody-Drug Conjugate Collaboration With Bayer Schering Pharma. Sep 8, 2009 700 Curis Announces GDC-0449 Phase I Clinical Data Published in New England Journal of Medicine. Sep 3, 2009 1663 OSI Pharmaceuticals Initiates Phase III Registration-Oriented Study for OSI-906 in Adrenocortical Carcinoma and Phase I/II Study in Ovarian Cancer. Sep 3, 2009 1158 Acceleron Pharma's ACE-031 Increases Lean Body Mass in Phase 1 Single Dose Clinical Trial. Sep 2, 2009 683 United States : NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate. Clinical report Sep 2, 2009 484 Biovail Announces Results from ACADIA's Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis. Sep 1, 2009 1177 ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis. Sep 1, 2009 1069 TransPharma Announces Successful Completion of Phase 2 Trial of ViaDerm-hPTH (1-34) in Postmenopausal Women with Osteoporosis. Sep 1, 2009 605 United Kingdom : NovaBiotics targets [pounds sterling]3bn market after fungus treatment trials. Sep 1, 2009 348 Clinical trial: a company-sponsored clinical study by Amgen Inc. found that its anemia drug Aranesp didn't improve heart conditions of patients with chronic kidney disease, but didn't hurt the patients either. Clinical report Aug 31, 2009 94 New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix[R] in Acute Coronary Syndrome Patients Undergoing Angioplasty. Clinical report Aug 30, 2009 1410 BioAlliance Pharma Announces Positive Preliminary Pivotal Phase III Results in Herpes Labialis with Acyclovir Lauriad[R]. Aug 26, 2009 454 Polymorph Applications: The Mexican Approach. Snchez-Huerta, Norma Aug 25, 2009 875 United States : Phase I/II trial with Amphinex using photochemical internalisation approach completed by PCI Biotech Holding. Aug 25, 2009 401 United States : Bioniche Phase III Clinical Trial With Urocidin(TM) Given Continued Green Light By DMC. Aug 25, 2009 384 Startup works on getting injectable migraine treatment to market: flush with funding, Zogenix advances FDA-approved product. Chambers, Heather Aug 24, 2009 715 Forest Announces Phase IIb Study Results For Oglemilast in Chronic Obstructive Pulmonary Disease. Clinical report Aug 19, 2009 617 Mount Sinai School of Medicine Added as Second Site for Provectus Pharmaceuticals' Phase 2 Clinical Study of PH-10 for Psoriasis. Clinical report Aug 18, 2009 632 Omnia Biologics and AparnaBio Sign Lentivirus Drug Development Agreement. Aug 18, 2009 232 Arena Pharmaceuticals cuts loss, focuses on obesity drug. Chambers, Heather Financial report Aug 10, 2009 406 Adventrx lays out strategy for chemotherapy drug. Chambers, Heather Brief article Aug 10, 2009 176 Napo Pharmaceuticals Completes Dose Selection Phase of ADVENT Trial. Aug 4, 2009 958 Weight loss drug maker Orexigen Therapeutics has raised a hefty $70.9 million through the sale of 10 million shares of common stock. Chambers, Heather Brief article Aug 3, 2009 136 BrainCells. Chambers, Heather Brief article Aug 3, 2009 112 State of the Clinical Trials Industry, 2009. Jul 1, 2009 149